Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.

Autoimmune encephalitis paraneoplastic encephalitis treatment guidelines

Journal

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
ISSN: 0317-1671
Titre abrégé: Can J Neurol Sci
Pays: England
ID NLM: 0415227

Informations de publication

Date de publication:
05 Feb 2024
Historique:
pubmed: 5 2 2024
medline: 5 2 2024
entrez: 5 2 2024
Statut: aheadofprint

Résumé

Autoimmune encephalitis is increasingly recognized as a neurologic cause of acute mental status changes with similar prevalence to infectious encephalitis. Despite rising awareness, approaches to diagnosis remain inconsistent and evidence for optimal treatment is limited. The following Canadian guidelines represent a consensus and evidence (where available) based approach to both the diagnosis and treatment of adult patients with autoimmune encephalitis. The guidelines were developed using a modified RAND process and included input from specialists in autoimmune neurology, neuropsychiatry and infectious diseases. These guidelines are targeted at front line clinicians and were created to provide a pragmatic and practical approach to managing such patients in the acute setting.

Identifiants

pubmed: 38312020
pii: S0317167124000167
doi: 10.1017/cjn.2024.16
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-21

Auteurs

Christopher Hahn (C)

Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.

Adrian Budhram (A)

Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada.
Department of Pathology and Laboratory Medicine, Western University, London Health Sciences Centre, London, ON, Canada.

Katayoun Alikhani (K)

Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.

Nasser AlOhaly (N)

Division of Neurology, University of Toronto, Toronto, ON, Canada.

Grayson Beecher (G)

Division of Neurology, University of Alberta, Edmonton, AB, Canada.

Gregg Blevins (G)

Division of Neurology, University of Alberta, Edmonton, AB, Canada.

John Brooks (J)

Division of Neurology, University of Toronto, Toronto, ON, Canada.

Robert Carruthers (R)

Division of Neurology, University of British Columbia, Vancouver, BC, Canada.

Jacynthe Comtois (J)

Neurosciences, Universite de Montreal Faculte de Medecine, Montreal, QC, Canada.

Juthaporn Cowan (J)

Division of Infectious Diseases, Department of Medicine Ottawa Hospital, Ottawa, ON, Canada.

Paula de Robles (P)

Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Department of Oncology, University of Calgary, Calgary, AB, Canada.

Julien Hébert (J)

Division of Neurology, University of Toronto, Toronto, ON, Canada.

Ronak K Kapadia (RK)

Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.

Sarah Lapointe (S)

Neurosciences, Universite de Montreal Faculte de Medecine, Montreal, QC, Canada.

Aaron Mackie (A)

Department of Psychiatry, University of Calgary, Calgary, AB, Canada.

Warren Mason (W)

Division of Neurology, University of Toronto, Toronto, ON, Canada.

Brienne McLane (B)

Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Department of Psychiatry, University of Calgary, Calgary, AB, Canada.

Alexandra Muccilli (A)

Division of Neurology, University of Toronto, Toronto, ON, Canada.

Ilia Poliakov (I)

Division of Neurology, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada.

Penelope Smyth (P)

Division of Neurology, University of Alberta, Edmonton, AB, Canada.

Kimberly G Williams (KG)

Department of Psychiatry, University of Calgary, Calgary, AB, Canada.

Christopher Uy (C)

Division of Neurology, University of British Columbia, Vancouver, BC, Canada.

Jennifer A McCombe (JA)

Division of Neurology, University of Alberta, Edmonton, AB, Canada.

Classifications MeSH